• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice.

作者信息

Nord E

机构信息

National Institute of Public Health, Norway.

出版信息

Int J Technol Assess Health Care. 1996 Winter;12(1):31-44. doi: 10.1017/s0266462300009363.

DOI:10.1017/s0266462300009363
PMID:8690560
Abstract

In the last two decades a number of health status index models have been developed for assessing the value of health outcomes in terms of quality-adjusted life years. The models can be tested by comparing their implications with direct observations of how societies think resources should be distributed across patient groups. This paper reviews empirical evidence of this kind from various countries and summarizes the evidence in three rules of thumb for selecting values for health states. Nine different models are judged relative to these rules of thumb. Eight of the models underestimate the strength of social preferences for treating the severely ill before the less severely ill. The ninth has a strong bias against states associated with emotional distress. As a consequence, none of the models can be seen as sufficient stand-alone instruments for valuing health outcomes. Instead, the models may be seen as complementary and adjustable parts of a tool kit that should also include the rules of thumb suggested in this paper.

摘要

相似文献

1
Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice.
Int J Technol Assess Health Care. 1996 Winter;12(1):31-44. doi: 10.1017/s0266462300009363.
2
A note on cost-value analysis.关于成本效益分析的一则注释。
Health Econ. 2003 Mar;12(3):247-50; discussion 251-3. doi: 10.1002/hec.719.
3
Resource allocation, social values and the QALY: a review of the debate and empirical evidence.资源分配、社会价值观与质量调整生命年:关于这场辩论及实证证据的综述
Health Expect. 2002 Sep;5(3):210-22. doi: 10.1046/j.1369-6513.2002.00182.x.
4
Algorithms for resource allocation of substance abuse prevention funds based on social indicators: a case study on state of Florida--Part 3.基于社会指标的药物滥用预防资金资源分配算法:以佛罗里达州为例——第3部分
J Drug Educ. 1998;28(4):283-306. doi: 10.2190/K481-P34V-L8VR-GBQJ.
5
Severity of illness and priority setting in healthcare: a review of the literature.疾病严重程度和医疗保健中的优先事项设定:文献回顾。
Health Policy. 2009 Dec;93(2-3):77-84. doi: 10.1016/j.healthpol.2009.08.005. Epub 2009 Aug 27.
6
The person-trade-off approach to valuing health care programs.评估医疗保健项目的个人权衡方法。
Med Decis Making. 1995 Jul-Sep;15(3):201-8. doi: 10.1177/0272989X9501500302.
7
Moral judgments in the rationing of health care resources: a comparative study of clinical health professionals.医疗保健资源分配中的道德判断:临床医疗专业人员的比较研究
Soc Work Health Care. 1997;25(4):13-36. doi: 10.1300/J010v25n04_02.
8
How stable are people's preferences for giving priority to severely ill patients?人们优先救治重症患者的偏好有多稳定?
Soc Sci Med. 1999 Oct;49(7):895-903. doi: 10.1016/s0277-9536(99)00174-4.
9
Social values, socioeconomic resources, and effectiveness coefficients. An ethical model for statistically based resource allocation.
Ann N Y Acad Sci. 2000 Sep;913:23-31. doi: 10.1111/j.1749-6632.2000.tb05158.x.
10
Investigating public preferences on 'severity of health' as a relevant condition for setting healthcare priorities.调查公众对“健康严重程度”作为确定医疗保健优先事项的相关条件的偏好。
Soc Sci Med. 2009 Jun;68(12):2247-55. doi: 10.1016/j.socscimed.2009.03.020. Epub 2009 May 4.

引用本文的文献

1
Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies.罕见病治疗方法的评估:社会偏好研究的系统文献综述。
Adv Ther. 2023 Feb;40(2):393-424. doi: 10.1007/s12325-022-02359-z. Epub 2022 Dec 1.
2
A methodological guide to performing a cost-utility study comparing surgical techniques.一项比较手术技术的成本效用研究的方法指南。
Can J Plast Surg. 2004 Winter;12(4):179-87. doi: 10.1177/229255030401200404.
3
Theory of constraints for publicly funded health systems.公共资助卫生系统的约束理论。
Health Care Manag Sci. 2013 Mar;16(1):62-74. doi: 10.1007/s10729-012-9208-9. Epub 2012 Aug 21.
4
Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.HIV/AIDS患者中15D、EQ-5D和SF-6D基于偏好的效用比较。
Qual Life Res. 2005 May;14(4):971-80. doi: 10.1007/s11136-004-3211-7.
5
Towards cost-value analysis in health care?迈向医疗保健中的成本效益分析?
Health Care Anal. 1999;7(2):167-75. doi: 10.1023/A:1009489122094.
6
Willingness to pay for a QALY: theoretical and methodological issues.支付意愿以获取一个质量调整生命年:理论与方法学问题。
Pharmacoeconomics. 2005;23(5):423-32. doi: 10.2165/00019053-200523050-00002.
7
Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications.1型糖尿病患者有无长期并发症症状时的健康相关生活质量。
Qual Life Res. 2002 Aug;11(5):427-36. doi: 10.1023/a:1015684100227.
8
Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.两种多属性效用测量方法在慢性阻塞性肺疾病患者中的信度、效度及反应度
Qual Life Res. 1999;8(1-2):45-54. doi: 10.1023/a:1026475531996.
9
Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial.美法仑联合泼尼松加或不加α-干扰素2b治疗新诊断多发性骨髓瘤的成本效用分析。一项随机对照试验的结果
Pharmacoeconomics. 1997 Jul;12(1):89-103. doi: 10.2165/00019053-199712010-00009.